Signaling Pathways - Sphingosine kinases (SphKs) - DOT1L - PKG - EP300
清除全部
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A5072 GSK690693Target: Akt|PKC|PKG|PKA|PrkSummary: ATP竞争性的Pan-AKT抑制剂
- A4491 SGC-CBP302 CitationTarget: CREBBP|EP300Summary: CREBBP/EP300 bromodomain抑制剂
- A4490 I-CBP 112Target: CREBBP|EP300Summary: CBP/EP300 bromodomain抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂